A. Kjeldsen

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

C. Shovlin, E. Buscarini, U. Sure, 2019, Orphanet Journal of Rare Diseases.

The European rare disease network for HHT frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care.

C. Shovlin, E. Buscarini, U. Sure, 2021, European journal of medical genetics.

Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT)

A. Kjeldsen, P. Andersen, H. Oxhøj, 2000, Journal of internal medicine.

Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia

H. Nissen, A. Kjeldsen, P. Andersen, 2014, Acta neurologica Scandinavica.

JP–HHT phenotype in Danish patients with SMAD4 mutations

M. Andersen, A. Gerdes, K. Brusgaard, 2016, Clinical genetics.

Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patients

A. Kjeldsen, P. Vase, A. Green, 1999, Journal of internal medicine.

Mutations in endoglin and in activin receptor‐like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia

K. Brusgaard, M. Hørder, T. Kruse, 2004, Clinical genetics.